01—Abstract
Summary
Summary of the 10-Q filed May 4, 2017. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported solid financial performance for the first quarter of 2017, with net income increasing by 9% to $399.8 milliona, or $1.18 per diluted share.
Total revenues saw a slight decrease of 1% to $929.3 millionb, primarily due to a 1% dip in clearing and transaction fees, despite a 3% increase in overall contract volume. This revenue decline was offset by a significant 9% reduction in total expenses, leading to an improved operating margin of 64.7% compared to 61.4% in the prior year quarter.
The company benefited from strong non-operating income, which surged to $105.8 millionc from $4.6 million, largely driven by the sale of its remaining stake in BM&FBOVESPA and increased investment income from reinvested performance bond collateral. Despite a higher effective tax rate of 43.5% in the current quarter, the overall operational and investment gains contributed to a robust increase in profitability.
02—Key points
Key Highlights
- Net income rose 9% to $399.8 million, with diluted EPS increasing to $1.18 from $1.09 year-over-year.
- Total revenues decreased slightly by 1% to $929.3 million, while total expenses fell significantly by 9% to $328.1 million.
- Operating margin improved to 64.7% from 61.4% in the prior year's first quarter.
- Clearing and transaction fees were down 1% to $792.0 million, despite a 3% increase in total contract volume to 1,060.1 million contracts.
- Interest rate product volumes increased significantly (11% average daily volume), driven by uncertainty in Federal Reserve interest rate policy and geopolitical events.
- Equity product volumes saw a notable decrease of 22% in average daily volume, attributed to lower market volatility.
- The company realized a gain of $86.5 million from the sale of its remaining shares in BM&FBOVESPA, contributing to a substantial increase in non-operating income.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2017filed May 4, 2017Financial Statements
Q1 FY2017 against Q1 FY2016
| Line item | Q1 FY2017Q1 FY2016 | Change |
|---|---|---|
| Revenue | $929.30M$934.20M | −0.5% |
| Operating Expenses | $328.40M$360.30M | −8.9% |
| Operating Income | $600.90M$573.90M | +4.7% |
| Net Income | $399.80M$367.80M | +8.7% |
| EPS (Basic) | $1.18$1.09 | +8.3% |
| EPS (Diluted) | $1.18$1.09 | +8.3% |
| Shares Outstanding (Basic) | 338.34M337.01M | +0.4% |
| Shares Outstanding (Diluted) | 339.95M338.55M | +0.4% |
05—Questions
Frequently Asked Questions
What drove the increase in net income despite a slight revenue decrease?
The increase in net income was primarily driven by a significant 9% reduction in total operating expenses and a substantial surge in non-operating income. The sale of the BM&FBOVESPA stake and increased investment income from reinvested collateral contributed to this boost, more than compensating for the modest dip in revenues.
How did changes in contract volume and average rate per contract affect clearing and transaction fees?
Total contract volume increased by 3% to 1,060.1 million contracts. However, the average rate per contract decreased by 3% to $0.731. The increase in volume contributed positively by an estimated $20.0 million, but the decrease in the average rate per contract resulted in an estimated $26.4 million decrease, leading to a net $6.4 million decrease in clearing and transaction fees.
What are the key factors influencing the performance of different product lines?
Interest rate products saw increased volume due to Federal Reserve policy uncertainty and geopolitical events. Conversely, equity product volumes decreased due to lower market volatility. Foreign exchange volumes declined due to lower volatility, though British pound volumes saw an increase driven by Bank of England policy. Agricultural and energy product volumes remained relatively stable or saw modest changes, while metals volumes increased as investors sought safe-haven assets.
Are there any significant regulatory or legal matters impacting the company?
The company is involved in a CFTC lawsuit against NYMEX concerning the disclosure of confidential customer information. While the company believes it has strong defenses, the outcome is uncertain. Management believes that the ultimate resolution of all legal and regulatory matters will not have a material impact on its financial position or results of operations, though they cannot predict the specific outcome or timing.
06—Continue